• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

Webinar “Coping with Lung Cancer: Sexuality and Body Image”

Join us on June 26th, 2023, at 5 PM CET for our next webinar “Coping with Lung Cancer: Sexuality and Body Image”

Workshop on “Knowledge on Artificial Intelligence applied to treatments decision-making”

As a member of the Horizon I3Lung project, Lung Cancer Europe (LuCE) will hold a workshop to explore the knowledge and trust on Artificial Intelligence (AI) of people impacted by lung cancer across Europe. Deadline to apply is June 15th, 2023.

8th LuCE Report – SURVEY: Financial impact of lung cancer. A European perspective.

8th LuCE Report – SURVEY: Financial impact of lung cancer. A European perspective: We are collecting data through an online survey, which objective is to explore the financial repercussions and difficulties experienced by people impacted by lung cancer in Europe.

A warm welcome to LuCE’s New Board

We wish to announce the newly elected LuCE Executive Board elected at the Annual General Meeting on 13 May 2023.

ERS International Congress 2023: Registration for patient representatives is now open.

The European Respiratory Society (ERS) International Congress 2023 will take place from 9–13 September 2023. It will be a hybrid conference, with the option to participate online or in person in Milan, Italy. Registration for representatives of patient organisations is now open.

EPF Artificial Intelligence Survey

EPF began engaging in Artificial Intelligence (AI) in healthcare in 2020, from both a policy and capacity- building perspective.

Highlights of ELCC 2023

Lung Cancer Europe – Highlights of #ELCC2023

Incontinence and Mental Health: Call for Evidence on a Comprehensive Approach to Mental Health

In the 2022 State of the European Union address, European Commission President von den Leyen announced a new European Mental Health Strategy. As a result of this announcement, the European Commission has begun to develop a programme of work.​​​​​​​

LuCE supports the WECAN statement concerning recent reports about the ECPC

LuCE is proud to support the WECAN statement concerning recent reports about the European Cancer Patient Coalition (ECPC) and the potential impact on EU research projects.

I3LUNG Study to Revolutionize Lung Cancer Treatment Launches Website

The I3LUNG project funded by the European Commission and promoted by MEDSIR, an independent clinical research company in oncology based in Barcelona, ​​the Instituto Nazionale dei Tumori in Milan and other European institutions has launched a new website.

1 : 00 AM

Hour
Minutes
AM PM
1 2 3 4 5 6 7 8 9 10 11 12